InspireMD, Inc. Series B Warrants
NSPRZ
NSPRZ was delisted on the 14th of March, 2022.
5 hedge funds and large institutions have $74K invested in InspireMD, Inc. Series B Warrants in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
48% less capital invested
Capital invested by funds: $142K → $74K (-$68K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$434 |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$33 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3 |
Top Sellers
NSPRZ Hedge Fund Activity: Q4 2017 in Review
5 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q4 2017, worth a combined $74K — down 48% from $142K a quarter earlier.
Fund positioning in NSPRZ was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, adding an estimated $434.
- 5 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $74K of InspireMD, Inc. Series B Warrants stock for Q4 2017, down 48% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Series B Warrants positions in Q4 2017 and 0 closed out.
- The largest InspireMD, Inc. Series B Warrants buyer in Q4 2017 was Virtu Financial, an estimated $434 added.
Based on aggregated 13F filings for Q4 2017.